| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 130, 261-267, Copyright © 1988 by American Society for Investigative Pathology
REGULAR ARTICLES |
DB Smith, PA Janmey and SE Lind
Hematology-Oncology Unit, Massachusetts General Hospital, Boston 02114.
Plasma gelsolin is one of two extracellular proteins that bind actin, a major body protein, with high affinity. The authors performed a series of experiments to determine whether tissue injury leads to actin release and the formation of circulating actin-gelsolin complexes. Two functions of plasma gelsolin, filament-nucleating and filament-severing activity, were used to measure total and free gelsolin concentrations, respectively. Both gelsolin and gelsolin-actin complexes nucleate actin assembly, whereas only free gelsolin severs actin filaments. Therefore, nucleation reflects the total gelsolin concentration, severing, the free gelsolin concentration, and the difference, gelsolin-actin complexes. Injection of F-actin in the rat caused a reduction in the free, but not total, gelsolin levels, consistent with the formation of circulating actin-gelsolin complexes. Oleic acid (50 mg/kg) administered intravenously in rats, a treatment that causes acute hemorrhagic pulmonary necrosis, caused the free gelsolin concentration to fall to a greater extent than the total gelsolin concentration, which indicated the presence of circulating actin-gelsolin complexes. Lower doses (9-27 mg/kg) in rabbits caused a qualitatively similar but smaller change in the free gelsolin level. Plasma gelsolin was immunoprecipitated at times when actin-gelsolin complexes were present, as determined functionally, and bound actin was demonstrated by immunoblotting with an anti-actin antiserum. These studies show that considerable amounts of actin are released into the extracellular space during acute lung injury and that circulating actin-gelsolin complexes can be detected in the peripheral blood.
This article has been cited by other articles:
 |
|
 |
|
  M. J. DiNubile Plasma gelsolin: in search of its raison d'etre. Focus on "Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin" Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1240 - C1242. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Candiano, M. Bruschi, N. Pedemonte, E. Caci, S. Liberatori, L. Bini, C. Pellegrini, M. Vigano, B. J. O'Connor, T. H. Lee, et al. Gelsolin Secretion in Interleukin-4-treated Bronchial Epithelia and in Asthmatic Airways Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1090 - 1096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Becker, A. A. Kazi, R. Wadgaonkar, D. B. Pearse, D. Kwiatkowski, and J. G. N. Garcia Pulmonary Vascular Permeability and Ischemic Injury in Gelsolin-Deficient Mice Am. J. Respir. Cell Mol. Biol., April 1, 2003; 28(4): 478 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. DiNubile, T. P. Stossel, O. C. Ljunghusen, J. L. M. Ferrara, and J. H. Antin Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantation Blood, December 15, 2002; 100(13): 4367 - 4371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. ERUKHIMOV, Z.-L. TANG, B. A. JOHNSON, M. P. DONAHOE, J. A. RAZZACK, K. F. GIBSON, W. M. LEE, K. J. WASSERLOOS, S. A. WATKINS, and B. R. PITT Actin-Containing Sera From Patients With Adult Respiratory Distress Syndrome Are Toxic to Sheep Pulmonary Endothelial Cells Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 288 - 294. [Abstract] [Full Text]
|
|
|
|
|
|
K. C. MOUNZER, M. MONCURE, Y. R. SMITH, and M. J. DINUBILE Relationship of Admission Plasma Gelsolin Levels to Clinical Outcomes in Patients after Major Trauma Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1673 - 1681. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
